López Serrano P, Martín Scapa M A, Alemán Villanueva S, Vázquez M, Cid Gómez L
Hospital Ramón y Cajal, Madrid.
An Med Interna. 2003 Sep;20(9):473-6.
Portal vein thrombosis (PVT) is the most frequent cause of hypertension portal extrahepatic. It is a rare disorder an the main risk factors are cirrhosis, hepatobiliary malignancies and prothrombotic disorders, which have been identified as major risk. Therapy with anticoagulants must to be considered in acute portal thrombosis or chronic one and proven hypercoagulability. We present the case of a twenty-nine years old patient, with extrahepatic portal hypertension secondary to portal and splenic vein thrombosis, who was diagnosed because of splenomegaly and a coagulation disorder. A protein C deficiency were discovered and anticoagulation and beta-blocker therapy were initiated. One year later the patient had not presented complications concerning to the disease or to the treatment.
门静脉血栓形成(PVT)是肝外门静脉高压最常见的原因。它是一种罕见的疾病,主要危险因素是肝硬化、肝胆恶性肿瘤和血栓前状态,这些已被确定为主要风险因素。对于急性门静脉血栓形成或慢性门静脉血栓形成且已证实存在高凝状态的患者,必须考虑使用抗凝剂进行治疗。我们报告一例29岁患者,因门静脉和脾静脉血栓形成继发肝外门静脉高压,因脾肿大和凝血障碍而被诊断。发现蛋白C缺乏,并开始抗凝和β受体阻滞剂治疗。一年后,患者未出现与疾病或治疗相关的并发症。